US Patent 7511066 Antithrombotic aromatic ethers
Patent 7511066 was granted and assigned to Eli Lilly and Company on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+345 characters)
Article
Patent abstract
This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07511066 Antithrombotic aromatic ethers US Patent 7511066 Antithrombotic aromatic ethers
Infobox
Patent Number
0751106600
Patent Number
751106600
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075110660
Date of Patent
March 31, 2009
0Patent Application Number
105713730
Date Filed
September 24, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075110660
Date of Patent
March 31, 2009
0Patent Application Number
105713730
Date Filed
September 24, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07511066 Antithrombotic aromatic ethers
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07511066
Date of patent
March 31, 2009
Patent application number
10571373
Date Filed
September 24, 2004
Patent primary examiner
Find more entities like US Patent 7511066 Antithrombotic aromatic ethers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
